Kevin McCulloch SEC EDGAR Filings (CIK 0002031695)

SEC EDGAR filings, ownership reports, and insider transactions for Kevin McCulloch.

Business address
Xeris Biopharma Holdings, Inc., 1375 West Fulton Street, Suite 1300, Chicago, IL, 60607
Top holdings (ownership)
XERS
Get insider transactions for this reporting owner
Kevin McCulloch has filed 12 SEC EDGAR filings since 02 Aug 2024

Latest Filings

Recent SEC filings for Kevin McCulloch including 4, 144, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 02 Feb 2026 30 Jan 2026 001-40880
4 Open 4 document View SEC filing for 4 FORM 4 09 Jan 2026 08 Jan 2026 001-40880
144 Open 144 document View SEC filing for 144 08 Jan 2026
4 Open 4 document View SEC filing for 4 FORM 4 03 Oct 2025 02 Oct 2025 001-40880
4 Open 4 document View SEC filing for 4 FORM 4 15 Sep 2025 11 Sep 2025 001-40880
4 Open 4 document View SEC filing for 4 FORM 4 04 Aug 2025 01 Aug 2025 001-40880
4 Open 4 document View SEC filing for 4 FORM 4 16 Jun 2025 13 Jun 2025 001-40880
4 Open 4 document View SEC filing for 4 FORM 4 03 Apr 2025 02 Apr 2025 001-40880
4 Open 4 document View SEC filing for 4 FORM 4 03 Feb 2025 31 Jan 2025 001-40880
4 Open 4 document View SEC filing for 4 FORM 4 07 Jan 2025 03 Jan 2025 001-40880
4 Open 4 document View SEC filing for 4 FORM 4 02 Aug 2024 01 Aug 2024 001-40880
3 Open 3 document View SEC filing for 3 FORM 3 02 Aug 2024 01 Aug 2024 001-40880

About this filer

Kevin McCulloch files with the SEC under CIK 0002031695. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages